Extended follow-up from JAVELIN Renal 101: subgroup analysis of avelumab plus axitinib versus sunitinib by the International Metastatic Renal Cell Carcinoma Database Consortium risk group in patients with advanced renal cell carcinoma - Concepedia

Concepedia

Publication | Open Access

Extended follow-up from JAVELIN Renal 101: subgroup analysis of avelumab plus axitinib versus sunitinib by the International Metastatic Renal Cell Carcinoma Database Consortium risk group in patients with advanced renal cell carcinoma

DOI Full Paper Access

52

Citations

11

References

2023

Year

John B.A.G. Haanen, James Larkin, Toni K. Choueiri, Laurence Albigès, Brian I. Rini, Michael B. Atkins, Manuela Schmidinger, Konstantin Penkov, Elisabete Michelon, J. Wang,

References

	Year	Citations

Page 1